Weitz & Luxenberg is accepting cases involving birth defects in children whose mothers used wakefulness medications Provigil (modafinil) or Nuvigil (armodafinil) during pregnancy. Provigil and…
Read MoreFirm News: Drugs & Devices: Page 4
Category: Drugs & Devices
W&L Accepting Homeopathic Teething Product Injury Cases
Weitz & Luxenberg is now accepting cases of children or infants who were injured after using homeopathic teething tablets and gels produced by Hyland’s…
Category: Drugs & Devices
W&L Accepting DePuy Synthes Radial Head Prosthesis System Failure Cases
Weitz & Luxenberg is now accepting cases of patients who are experiencing complications or needed revision surgery because of the DePuy Synthes’ Radial Head…
Category: Drugs & Devices
FDA Reviewing SGLT2 Inhibitors and Acute Pancreatitis Reports
Updated September 14, 2017. Following reports of acute pancreatitis among people taking a type of diabetes medication, the U.S. Food and Drug Administration (FDA)…
Category: Drugs & Devices
Danielle Gold Speaks on Stryker LFIT V40 Litigation at AAJ Mass Torts Seminar
Danielle Gold, an associate attorney in Weitz & Luxenberg’s Drug and Medical Device Litigation group, will participate in a discussion on Stryker’s LFIT V40…
Category: Drugs & Devices
Onglyza & Kombiglyze XR
Onglyza and Kombiglyze XR are approved for use with diet and exercise to control blood sugar in adults with type 2 diabetes. Results from…